A benzodiazepine receptor antagonist decreases sleep and reverses the hypnotic actions of flurazepam.
W B Mendelson, M Cain, J M Cook, S M Paul, P Skolnick
Index: Science 219(4583) , 414-6, (1983)
Full Text: HTML
Abstract
The benzodiazepine receptor antagonist 3-hydroxymethyl-beta-carboline, which blocks several of the pharmacological actions of benzodiazepines, induces a dose-dependent increase in sleep latency in the rat. Furthermore, at a low dose that by itself does not affect sleep, 3-hydroxymethyl-beta-carboline blocks sleep induction by a large dose of flurazepam. The benzodiazepine receptor may play a role in both the physiological regulation and pharmacological induction of sleep.
Related Compounds
Related Articles:
1982-01-01
[Prog. Clin. Biol. Res. 90 , 253-61, (1982)]
Electrophysiological studies on benzodiazepine antagonists.
1984-03-19
[Brain Res. 295(2) , 265-74, (1984)]
1985-10-01
[Neuropharmacology 24(10) , 957-63, (1985)]
3-hydroxymethyl-beta-carboline antagonizes some pharmacologic actions of diazepam.
1981-02-19
[Eur. J. Pharmacol. 69(4) , 525-7, (1981)]
Beta-carbolines as antagonists of the discriminative stimulus effects of diazepam in rats.
1988-07-01
[J. Pharmacol. Exp. Ther. 246(1) , 275-81, (1988)]